Understanding your personal GLP-1 biology not just your weight or your diet gives you a more accurate picture of your actual metabolic risk
Retatrutide is a single peptide formulated to activate 3 metabolic hormone receptors at once: GLP-1 receptor agonism: This may slow gastric emptying, increases satiety signals to the brain, enhances glucose-dependent insulin secretion GIP receptor agonism: This enhances insulin secretion and may improve fat metabolism in preclinical models Glucagon receptor agonism: This may increase energy expenditure and hepatic fat oxidation in research settings Retatrutide works by mimicking 3 gut / liver hormones to increase insulin, reduce appetite, slow digestion, and raise energy burn
If you plan to stack both of these peptides, you need to closely follow up with your healthcare professional so that he/she can track your progress in the right manner
There is emerging evidence that GLP-1s may also be useful in treating long COVID, helping people drink and smoke less and reducing substance abuse
No known direct drug interactions GLP-1 medications and hormone therapies do not directly interact at the receptor or enzyme level
Orforglipron has no cardiovascular outcomes data